This is a preview of subscription content, log in via an institution to check access.
REFERENCE
Tunis SL, Minshall ME, Bron M, Baran RW, Pandya BJ.Long-term economic value of a hypothetical DPP-4 inhibitor for the treatment of type 2 diabetes mellitus: the potential impact of the preservation of beta-cell function. Diabetes 57 (Suppl. 1): 345 (plus poster) abstr. 1211-P, Jun 2008
Rights and permissions
About this article
Cite this article
DPP-IV inhibitors could be cost-effective for T2DM. Pharmacoecon. Outcomes News 556, 5 (2008). https://doi.org/10.2165/00151234-200805560-00011
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200805560-00011